ACT-660602 | m-entrepreneurship.com

Product Name :
ACT-660602

Search keywords :
ACT-660602

drugId :
null

Target Vo:
C-X-C motif chemokine receptor 3

Target Vo Short Name :
CXCR3

Moa_Name:
C-X-C motif chemokine receptor 3 antagonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Idorsia Pharmaceuticals Ltd

Active Company_Name :
Idorsia Pharmaceuticals Ltd

Active Indication_Name:
Autoimmune Diseases

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Acetyl-p53 (Lys370) Rabbit mAb Description
Ocaratuzumab web
Phospho-ATM (S1981) Antibody: Phospho-ATM (S1981) Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 351 kDa, targeting to Phospho-ATM (S1981). It can be used for WB,ICC/IF,IHC-P,IP assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts